SANDY KING: Open Payments
NPI 1972270445 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 27 payments from 11 companies in 2025. Trend: 2023 $88 · 2024 $119 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 13 | $154 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
Products named: Qelbree, AUSTEDO XR, REXULTI, ABILIFY ASIMTUFII, Auvelity, FANAPT, Rybelsus, ZEPBOUND.
Industry payments across AR — which companies pay providers there.
